Mette Bjerre

Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Sune Folke Pedersen, SUND ph.d. skole, Danmark
  • Mette Bjerre
  • Rasmus Mogelvang
  • ,
  • Jan Frystyk
  • Allan Flyvbjerg, Danmark
  • Soren Galatius
  • ,
  • Tor Biering Sørensen
  • ,
  • Allan Iversen, Institut for Klinisk Medicin, Danmark
  • Anders Hvelplund, Afdeling for Almen Medicin, Danmark
  • Jan Skov Jensen, Kirurgi og Intern Medicin, Danmark
Osteoprotegerin (OPG) is a glycoprotein with a regulatory role in immune, skeletal and vascular systems. Data suggest that high circulating OPG levels are associated with an increased risk of cardiovascular disease. We analyzed the association between OPG and long-term outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI).
OriginalsprogEngelsk
TidsskriftCardiology
Vol/bind123
Nummer1
Sider (fra-til)31-8
Antal sider8
ISSN0008-6312
DOI
StatusUdgivet - 2012

Se relationer på Aarhus Universitet Citationsformater

ID: 52527210